OM1 - About the company
OM1 is a series C company based in Cambridge (United States), founded in 2015 by Richard Gliklich. It operates as a Platform that enables providers to manage CMS CJR bundle for value-based care. OM1 has raised $171M in funding from investors like Polaris Partners, Scale Venture Partners and Kaiser Permanente. The company has 689 active competitors, including 75 funded and 45 that have exited. Its top competitors include companies like Ovation, Kyruus Health and Truveta.
Company Details
Platform that enables providers to manage CMS CJR bundle for value-based care. Features include Actionable insights for improving clinical, financial and operational performance; Automates PRO collection with a mobile-first-consumer engaging approach Generates condition scores for the hospital, provider and the patient Works standalone or fully integrated with major EMRs, and Provides predictive capabilities that will lower risk and improve financial performance under CJR.
- Website
- www.om1.com/
- Phone Number
- +1 **********
- Registered Address
- Boston, Massachusetts
Key Metrics
Founded Year
2015
Location
Cambridge, United States
Stage
Series C
Total Funding
$171M in 4 rounds
Latest Funding Round
Investors
Ranked
6th among 689 active competitors
Employee Count
93 as on Sep 30, 2026
Similar Companies
Legal entities associated with OM1
OM1 is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Om1, Inc. CIN: 810863129 , United States, Active | Dec 31, 2014 | - | 115 (As on Dec 31, 2024) | - |
Sign up to download OM1's company profile
OM1's funding and investors
OM1 has raised a total funding of $171M over 4 rounds. Its first funding round was on Apr 06, 2017. Its latest funding round was a Series C round on Jul 16, 2021 for $*****. 6 investors participated in its latest round. OM1 has 9 institutional investors.
Here is the list of recent funding rounds of OM1:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jul 16, 2021 | 9629083 | Series C | 2223361 | 9843530 | 8456569 | 9088295 |
Dec 17, 2019 | 6465905 | Series C | 9230043 | 2529724 | 6663780 | |
May 22, 2018 | 6698613 | Series B | 4471724 | 4631805 |
View details of OM1's funding rounds and investors
OM1's founders and board of directors
Founder? Claim ProfileThe founders of OM1 is Richard Gliklich. Richard Gliklich is the CEO of OM1.
Here are the details of OM1's key team members:
- Richard Gliklich: Founder & CEO of OM1 and founder of 1 other company. They are also an angel investor in 1 startup.Contact Info: 1 email address
OM1's Board of Directors
OM1's board has 5 active members. David Barrett, Larry Bohn, Rory O'Driscoll, Gary Gottlieb and Richard E. Gliklich are independent board members.Here is the list of OM1's board of directors:
Name | Type | Representing | Status | Duration |
|---|---|---|---|---|
Independent board member | - | Current | 5y 1m | |
xzxm{qi | Independent board member | - | Current | 5y 9m |
bceqmv{ | Independent board member | - | Current | 3y 2m |
zmlzwci | Independent board member | - | Current | 6y 6m |
prsyqos | Independent board member | - | Current | 1y 1m |
View details of OM1's Founder profiles and Board Members
OM1's employee count trend
OM1 has 93 employees as of Sep 26. Here is OM1's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
OM1's Competitors and alternates
Top competitors of OM1 include Ovation, Kyruus Health and Truveta. Here is the list of Top 10 competitors of OM1, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Ovation 2009, Cambridge (United States), Series B | Provider of a cloud-based laboratory information and data management platform for researchers and clinicians | $33.3M | 69/100 | |
2nd | Kyruus Health 2010, Boston (United States), Acquired | Provider of software solutions for clinical decision making | $196M | 68/100 | |
3rd | Truveta 2020, Seattle (United States), Series C | Provider of healthcare data platform for learning services | $515M | 65/100 | |
4th | Carta Healthcare 2017, San Mateo (United States), Series B | Provider of an AI platform for clinical data management solutions | $80.6M | 64/100 | |
5th | Abacus Insights 2017, New York City (United States), Series C | Provider of data management solutions | $94.9M | 62/100 | |
6th | OM1 2015, Cambridge (United States), Series C | Platform that enables providers to manage CMS CJR bundle for value-based care | $171M | 62/100 | |
7th | Provider of an AI-based medical data management and mining platform for the healthcare industry | $200M | 62/100 | ||
8th | Motivity 2002, Seattle (United States), Series A | Provider of software for collecting data for clinics | $38M | 60/100 | |
9th | InterSystems 1978, Cambridge (United States), Acquired | Cloud based database management software | - | 59/100 | |
10th | nference 2013, Cambridge (United States), Series C | Provider of an AI platform for clinical data analysis and insights | $134M | 58/100 |
Looking for more details on OM1's competitors? Click here to see the top ones
OM1's Investments and acquisitions
OM1 has made no investments or acquisitions yet.
Reports related to OM1
Here is the latest report on OM1's sector:
News related to OM1
Media has covered OM1 for a total of 2 events in the last 1 year.
•
OM1 Supports 650,000 Patient Real-World Regulatory Submission for FDA Approval of Hologic's Aptima HPV AssayBusiness Wire•May 11, 2026•OM1
•
•
OM1 Appoints Hunter Lane as Chief Product Officer to Lead AI-Powered RWE SolutionsRad AI•Aug 05, 2025•OM1, Tempus
•
•
OM1 Expands into Europe to Strengthen Support for Life Sciences with AI-Driven Real-World Evidence SolutionsBusiness Wire•Mar 12, 2025•OM1
•
•
•
OM1 Contributes to Alzheimer’s Disease Research With New PremiOM Dataset of Over 1 Million PatientsBusiness Wire•Jul 30, 2024•OM1
•
•
OM1, a Pioneer in Patient Registries, Launches Its Registries Center of ExcellenceBusiness Wire•Jun 13, 2024•OM1
Are you a Founder ?
FAQs about OM1
Explore our recently published companies
- Oceanorganics - 1998 founded, Unfunded company
- Soilserviceinc - United States based, 2014 founded, Unfunded company
- AmieSheridan - Ardmore based, 2018 founded, Unfunded company
- Bhikharam Chandmal - Kolkata based, 1923 founded, Unfunded company
- Huishuochem - Unfunded company
- Modis-Italy - Unfunded company
